论文部分内容阅读
目的为了探讨通淋排石中药联合坦索罗辛在ESWL辅助治疗中应用效果,我们进行了本临床观察;方法将符合纳入指标患者随机分为治疗组和观察组,其中治疗组60例给予通淋排石中药联合坦索罗辛作为ESWL的辅助治疗;对照组60例碎石后给予对症处理,观察两组疗效;结果患者在碎石后的疼痛程度、碎石后血尿的持续时间以及结石的排净率等方面均优于对照组(P<0.05);结论患者在ESWL后的辅助治疗中应用通淋排石中药联合坦索罗辛能够显著提高碎石的疗效。
Objective To investigate the effect of Tonglinpai combined with tamsulosin in the ESWL adjuvant therapy, we conducted this clinical observation. Methods The patients who met the inclusion criteria were randomly divided into treatment group and observation group, of which 60 cases in treatment group Ditan row of Chinese medicine combined with tamsulosin as ESWL adjuvant therapy; control group of 60 cases of gravel given symptomatic treatment, the two groups were observed; the results of pain in the gravel after the gravel after the duration of hematuria and stones (P0.05) .Conclusion The application of Tonglin Paishi Chinese medicine combined with tamsulosin in the adjuvant therapy after ESWL can significantly improve the effect of gravel.